WebDisclosure WebDisclosure
Basculer en Français
11336 Companies
251963 Keywords
181324 Articles
137783 Press releases
Headlines Articles Press releases EMBARC Remove
  1. Home
  2. Companies
  3. EMBARC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/25/2026 at 11:10, 4 months 18 days ago

    EMBARC to Collaborate with Insmed on Brensocatib Study in Bronchiectasis

    Bronchiectasis Brensocatib EMBARC Insmed Collaboration Interventional Study
  • BRIEF

    published on 06/25/2026 at 11:10, 4 months 18 days ago

    EMBARC va collaborer avec Insmed sur une étude concernant le brensocatib dans la bronchectasie.

    Bronchectasie Brensocatib EMBARC Collaboration Insmed Étude Interventionnelle
  • PRESS RELEASE

    published on 06/25/2026 at 11:05, 4 months 18 days ago

    EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis

    EMBARC announces collaboration with Insmed on landmark interventional study evaluating disease modification potential of brensocatib in bronchiectasis. Study aims to enroll 3,000 patients across Europe
    Bronchiectasis EMBARC Interventional Study Insmed Disease Modification
    Logo of EMBARC
Accesswire
  • Published on 11/14/2026 at 01:30, 1 hour 45 minutes ago

    NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

  • Published on 11/14/2026 at 00:40, 2 hours 35 minutes ago

    BEACN Announces Annual General and Special Meeting Results

  • Published on 11/14/2026 at 00:35, 2 hours 40 minutes ago

    American Hotel Income Properties REIT LP Reports Q3 2026 Results

  • Published on 11/14/2026 at 00:00, 3 hours 15 minutes ago

    SLAM Announces Proposed Extension of Warrant Expiry Dates

  • Published on 11/13/2026 at 23:15, 4 hours ago

    Core Critical Metals Corp. Announces $500,000 Non-Brokered Critical Mineral Flow-Through Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 11/13/2026 at 23:24, 3 hours 50 minutes ago

    EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds

  • Published on 11/13/2026 at 21:52, 5 hours 22 minutes ago

    EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026

  • Published on 11/13/2026 at 19:15, 8 hours ago

    Increase in Equity to Accelerate Growth

  • Published on 11/13/2026 at 19:08, 8 hours 6 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026

  • Published on 11/13/2026 at 19:00, 8 hours 15 minutes ago

    Assemblée générale ordinaire des actionnaires le 18 décembre 2026

View all EQS
Les Echos
  • Published on 11/13/2026 at 17:45, 9 hours 30 minutes ago

    STEF : Droits de vote au 31-10-2026

  • Published on 11/13/2026 at 11:35, 15 hours 40 minutes ago

    ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France

  • Published on 11/13/2026 at 11:35, 15 hours 40 minutes ago

    ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France

  • Published on 11/13/2026 at 08:00, 19 hours 15 minutes ago

    Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€

  • Published on 11/12/2026 at 23:12, 1 day 4 hours ago

    Belgrano continues the implementation of its public share buyback offer (OPRA)

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy